Top Clinical Trials companies in Israel by Return on Assets (ROA)

This ranking features the top 9 Clinical Trials companies in Israel ranked by Return on Assets (ROA), averaging a Return on Assets (ROA) of -37.58%, for February 07, 2025.
#
Name
Return on Assets (ROA)
Reported Date
Stock Price
Change
Price (30 days) Country
1
2.33%
Dec. 31, 2023 USD 6.96 3.55%

Israel

2
0.91%
Dec. 31, 2023 USD 0.08 0.74%

Israel

3
-0.04%
Dec. 31, 2023 USD 0.02 -4.22%

Israel

4
-10.11%
Dec. 31, 2023 USD 19.58 -1.51%

Israel

5
-15.46%
Dec. 31, 2023 USD 2.38 4.02%

Israel

6
-27.15%
Dec. 31, 2023 USD 3.70 -2.63%

Israel

7
-77.78%
Dec. 31, 2023 USD 1.95 4.71%

Israel

8
-94.82%
Dec. 31, 2023 USD 0.01 -3.84%

Israel

9
-116.08%
Dec. 31, 2023 USD 0.11 3.21%

Israel

Frequently Asked Questions
  • Which Clinical Trials company in Israel has the highest Return on Assets (ROA) ?

    The Clinical Trials company in Israel with the highest Return on Assets (ROA) is Kamada Ltd. (Tel Aviv Stock Exchange: KMDA.TA) at 2.33%.

  • Which Clinical Trials company in Israel has the lowest Return on Assets (ROA) ?

    The Clinical Trials company in Israel with the lowest Return on Assets (ROA) is Tikun Olam-Cannbit Pharmaceuticals Ltd (Tel Aviv Stock Exchange: TKUN.TA) at -116.08%.

SV Wall Street